Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B
Clinical trial NCT02844491 · TERMINATED
Trial details
- NCT number
- NCT02844491
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-22
- Primary completion
- 2014-09-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.